Dominia Health provides telehealth consultations and may prescribe compounded medications, including compounded Semaglutide and compounded Tirzepatide, when clinically appropriate.
Compounded medications are not FDA-approved. The U.S. Food and Drug Administration (FDA) does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded Semaglutide and Tirzepatide are prepared by state-licensed compounding pharmacies pursuant to individual patient prescriptions and are not the same as, or generic equivalents of, FDA-approved brand-name medications such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
These compounded formulations are prescribed only after a licensed healthcare provider evaluates your individual medical history, health goals, and eligibility through a telehealth consultation. Not everyone is a candidate for treatment.
Results vary from person to person and are not guaranteed. Weight loss and other outcomes depend on many factors, including individual biology, adherence to the prescribed plan, lifestyle, and ongoing medical supervision. Any testimonials or patient stories shown on this website are illustrative of individual experiences and do not guarantee similar results.
The information on this website is for general educational purposes only and is not medical advice. It does not create a doctor-patient relationship. Always consult a qualified healthcare provider for personalized medical advice, diagnosis, or treatment decisions.
By using this website or requesting a consultation, you acknowledge that you understand the above statements regarding compounded medications and telehealth services.
